Determination of the impact of strain rate on dynamic recrystallization of hot-deformed 2205 duplex stainless steel

2205 duplex stainless steel suffers poor hot workability, especially whe1981hot-deformed. This investigation aims to determine the strain rate’s effect on the material’s dynamic recrystallization after heat treatment. Secondly, to ascertain the critical strain at which the recrystallization occurs. The as-rolled material was subjected to heat treatment at 1340 °C for some time. After heat treatment, the yielded equiaxed austenite morphology was used for this investigation. Gleeble 1500™ thermo-mechanical was used as a simulant in uniaxial compression mode. The deformation temperature was set at 850 °C, with maximum strain at 0.8 and carried out at 0.001 s-1, 0.01 s-1, 0.1 s-1, 1 s-1, 5 s-1 strain rates. The microstructure of before and after heat-treatment was evaluated using a light microscope, while the critical factors (stress and strain) were determined through the stress-strain curve. It was observed that the lowest strain rate generated the maximum critical stress and critical strain at 191.99 MPa and 0.08283, respectively. However, at the highest strain rate, the maximum critical stress and critical strain experienced by the material were at 336.32 MPa and 0.17577. Overall, it was established that the applied stain rate influenced the critical strain and stress of the material. It can be concluded that dynamic recrystallization can occur at any strain rate, but the applied stress determines the extent of the phenomenon

BLOOM+1: Adding Language Support to BLOOM for Zero-Shot Prompting

The BLOOM model is a large publicly available multilingual language model, but its pretraining was limited to 46 languages. To extend the benefits of BLOOM to other languages without incurring prohibitively large costs, it is desirable to adapt BLOOM to new languages not seen during pretraining. In this work, we apply existing language adaptation strategies to BLOOM and benchmark its zero-shot prompting performance on eight new languages in a resource-constrained setting. We find language adaptation to be effective at improving zero-shot performance in new languages. Surprisingly, we find that adapter-based finetuning is more effective than continued pretraining for large models. In addition, we discover that prompting performance is not significantly affected by language specifics, such as the writing system. It is primarily determined by the size of the language adaptation data. We also add new languages to BLOOMZ, which is a multitask finetuned version of BLOOM capable of following task instructions zero-shot. We find including a new language in the multitask fine-tuning mixture to be the most effective method to teach BLOOMZ a new language. We conclude that with sufficient training data language adaptation can generalize well to diverse languages. Our code is available at https://github.com/bigscience-workshop/multilingual-modeling

Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations

10.4103/0970-2113.116248Lung India303228-26

Enhanced infection prophylaxis reduces mortality in severely immunosuppressed HIV-infected adults and older children initiating antiretroviral therapy in Kenya, Malawi, Uganda and Zimbabwe: the REALITY trial

Meeting abstract FRAB0101LB from 21st International AIDS Conference 18–22 July 2016, Durban, South Africa. Introduction: Mortality from infections is high in the first 6 months of antiretroviral therapy (ART) among HIV‐infected adults and children with advanced disease in sub‐Saharan Africa. Whether an enhanced package of infection prophylaxis at ART initiation would reduce mortality is unknown. Methods: The REALITY 2×2×2 factorial open‐label trial (ISRCTN43622374) randomized ART‐naïve HIV‐infected adults and children >5 years with CD4 <100 cells/mm3. This randomization compared initiating ART with enhanced prophylaxis (continuous cotrimoxazole plus 12 weeks isoniazid/pyridoxine (anti‐tuberculosis) and fluconazole (anti‐cryptococcal/candida), 5 days azithromycin (anti‐bacterial/protozoal) and single‐dose albendazole (anti‐helminth)), versus standard‐of‐care cotrimoxazole. Isoniazid/pyridoxine/cotrimoxazole was formulated as a scored fixed‐dose combination. Two other randomizations investigated 12‐week adjunctive raltegravir or supplementary food. The primary endpoint was 24‐week mortality. Results: 1805 eligible adults (n = 1733; 96.0%) and children/adolescents (n = 72; 4.0%) (median 36 years; 53.2% male) were randomized to enhanced (n = 906) or standard prophylaxis (n = 899) and followed for 48 weeks (3.8% loss‐to‐follow‐up). Median baseline CD4 was 36 cells/mm3 (IQR: 16–62) but 47.3% were WHO Stage 1/2. 80 (8.9%) enhanced versus 108(12.2%) standard prophylaxis died before 24 weeks (adjusted hazard ratio (aHR) = 0.73 (95% CI: 0.54–0.97) p = 0.03; Figure 1) and 98(11.0%) versus 127(14.4%) respectively died before 48 weeks (aHR = 0.75 (0.58–0.98) p = 0.04), with no evidence of interaction with the two other randomizations (p > 0.8). Enhanced prophylaxis significantly reduced incidence of tuberculosis (p = 0.02), cryptococcal disease (p = 0.01), oral/oesophageal candidiasis (p = 0.02), deaths of unknown cause (p = 0.02) and (marginally) hospitalisations (p = 0.06) but not presumed severe bacterial infections (p = 0.38). Serious and grade 4 adverse events were marginally less common with enhanced prophylaxis (p = 0.06). CD4 increases and VL suppression were similar between groups (p > 0.2). Conclusions: Enhanced infection prophylaxis at ART initiation reduces early mortality by 25% among HIV‐infected adults and children with advanced disease. The pill burden did not adversely affect VL suppression. Policy makers should consider adopting and implementing this low‐cost broad infection prevention package which could save 3.3 lives for every 100 individuals treated